
- Volume 0 0
CONTRACEPTIVE SIGNS PLANNED FOR ILLINOIS PHARMACIES
The increasingly contentious"conscience-clause" battle betweenIllinois pharmacists and thestate's governor over access toemergency contraceptives is heatingup again. The latest wrinkle isnew rules proposed by the state'sDepartment of Financial and ProfessionalRegulation requiringevery Illinois pharmacy to post asign with information about awoman's right to obtain prescriptionsto prevent pregnancy.
That proposal was prompted byreports that some pharmacists inthe state have been attempting toget around new state rules requiringall pharmacies to carry contraceptiveproducts. Under the plan,the sign will disclose that the pharmacymust take one of the followingactions: provide a medicallyacceptable alternative drug; orderthe medication from the pharmacy'ssupplier if the patient requestsit; transfer the prescription to a differentpharmacy per the patient'srequest; and return the prescriptionorder to the patient if asked.
The sign also will provide patientswith a toll-free pharmacyhot-line number and a Web siteaddress if they wish to file a complaintfor unfair treatment by thepharmacy.
Additionally, Gov Rod R. Blagojevich(D, Ill) has fired off a newround of letters to all of the state'slicensed pharmacists remindingthem of their legal obligation to fillprescriptions for contraceptiveswithout delay.
Articles in this issue
over 19 years ago
A Good Night's Rest—Helping the Patient with Insomniaover 19 years ago
Is Sleep-Driving for Real?over 19 years ago
Painful Diabetic Neuropathy: Alternative Treatmentsover 19 years ago
A New Day Dawns for NCPA and NACDSover 19 years ago
compounding HOTLINEover 19 years ago
RESPy AWARDover 19 years ago
ULM STUDENT NEEDED TO HELPover 19 years ago
Must an Embezzling Pharmacist Repay Wages Received?over 19 years ago
Web-based Program Aids Health Care Industryover 19 years ago
Depression: Identifying Symptoms and Appropriate TreatmentNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.